%0 English Abstract
%T [Clinical characteristics and prognosis of children with perianal fistulizing Crohn's disease].
%A Fang YH
%A Luo YY
%A Zhang RF
%A Cheng Q
%A Chen J
%J Zhongguo Dang Dai Er Ke Za Zhi
%V 26
%N 1
%D 2024 Jan 15
%M 38269458
暂无%R 10.7499/j.issn.1008-8830.2308119
%X <B>OBJECTIVE: </B>To investigate the clinical characteristics, treatment, and prognosis of children with perianal fistulizing Crohn's disease (pfCD).<BR><B>METHODS: </B>A retrospective analysis was conducted on the children, aged 6-17 years, who were diagnosed with Crohn's disease (CD) from April 2015 to April 2023. According to the presence or absence of perianal fistulizing lesions, they were divided into two groups: pfCD (n=60) and non-pfCD (n=82). The two groups were compared in terms of clinical characteristics, treatment, and prognosis.<BR><B>RESULTS: </B>The incidence of pfCD was 42.3% (60/142). The proportion of males in the pfCD group was higher than that in the non-pfCD group. Compared with the non-pfCD group, the pfCD group had a significantly higher proportion of children with involvement of the colon and small intestine or those with upper gastrointestinal lesions (P<0.05). Compared with the non-pfCD group, the pfCD group had a significantly higher rate of use of infliximab during both induction and maintenance treatment (P<0.05). In the pfCD group, the children with complex anal fistula accounted for 62% (37/60), among whom the children receiving non-cutting suspended line drainage accounted for 62% (23/37), which was significantly higher than the proportion among the children with simple anal fistula patients (4%, 1/23) (P<0.05). There were no significant differences between the two groups in mucosal healing rate and clinical remission rate at week 54 of treatment (P>0.05). The pfCD group achieved a fistula healing rate of 57% (34/60) at week 54, and the children with simple anal fistula had a significantly higher rate than those with complex anal fistula (P<0.05).<BR><B>CONCLUSIONS: </B>There is a high incidence rate of pfCD in children with CD, and among the children with pfCD, there is a high proportion of children with the use of biological agents. There is a high proportion of children receiving non-cutting suspended line drainage among the children with complex anal fistula. The occurrence of pfCD should be closely monitored during the follow-up in children with CD.<BR>目的: 分析儿童肛周瘘管型克罗恩病（perianal fistulizing Crohn's disease, pfCD）患儿的临床特征、治疗及预后。方法: 回顾性选择2015年4月2023年4月间诊断为克罗恩病（Crohn's disease, CD）的6~17岁患儿142例为研究对象，根据是否存在肛周瘘管型病变，分为pfCD组（60例）和非pfCD组（82例），比较两组患儿的临床特征、治疗及预后。结果: pfCD发生率为42.3%（60/142）。pfCD组男性比例，病变范围累及结肠、小肠结肠比例，以及合并上消化道病变的比例高于非pfCD组（P<0.05）。pfCD组英夫利西单抗诱导缓解及维持缓解治疗比例高于非pfCD组（P<0.05）。pfCD组中，复杂性肛瘘患儿占62%（37/60），肛瘘非切割性挂线引流术治疗在复杂性肛瘘患儿中比例为62%（23/37），显著高于简单性肛瘘患儿（4%，1/23）（P<0.05）。两组患儿治疗54周黏膜愈合率和临床缓解率差异均无统计学意义（P>0.05）。pfCD组治疗54周瘘管愈合率为57%（34/60），其中简单性肛瘘患儿瘘管愈合率高于复杂性肛瘘患儿（P<0.05）。结论: 儿童CD患者中pfCD发生率高，pfCD患儿生物制剂使用比例高，复杂性肛瘘非切割性挂线引流术比例高，CD患儿随访中需要密切关注pfCD的发生。.